Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
about
Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New AntibacterialsCompounds that select against the tetracycline-resistance efflux pumpMultidrug evolutionary strategies to reverse antibiotic resistance.Macrophage adaptation leads to parallel evolution of genetically diverse Escherichia coli small-colony variants with increased fitness in vivo and antibiotic collateral sensitivity.Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus BacteremiaDrug repurposing screens and synergistic drug-combinations for infectious diseases.β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention.β-Lactams and β-Lactamase Inhibitors: An Overview.The rapid spread of carbapenem-resistant Enterobacteriaceae.Next-generation approaches to understand and combat the antibiotic resistome.Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus.Metabolic constraints on the evolution of antibiotic resistance.A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.Antimicrobial Nanomaterials Derived from Natural Products-A Review.Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.Identification of Collateral Sensitivity to Dihydroorotate Dehydrogenase Inhibitors in Plasmodium falciparum.Better living through chemistry: Addressing emerging antibiotic resistance.Aspermerodione, a novel fungal metabolite with an unusual 2,6-dioxabicyclo[2.2.1]heptane skeleton, as an inhibitor of penicillin-binding protein 2a.The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.Antibiotics: Synergistic MRSA combinations.PAK1 regulates ATXN1 levels providing an opportunity to modify its toxicity in Spinocerebellar ataxia type 1.Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli
P2860
Q26749531-72B64B04-3B5A-4190-AB59-E6EA2F140CC2Q28314905-469B5B0F-A7F2-4E55-A03B-EF21EDCD4B66Q33871101-96CC2702-FE16-416F-B55E-067455E15D79Q37208314-9499AB55-B678-44CA-AC0B-05AF0007BA3EQ37358638-45E58392-B63F-47F2-B3E4-5CBD0A720325Q38158092-D2348125-6764-4CA2-A3BF-B70A99D50961Q38811605-D67EC7F8-F78B-45D9-B0D9-9F22B8B76621Q38852902-584AAF3A-B242-4CC2-9ED4-F90BF4FBB9ABQ38872374-98E757C6-8A40-4593-A4C2-875F75AEBAF1Q39027434-8AD31F76-76B9-4F1D-988D-3D7D375A184CQ39230397-E33C0E81-7A0A-4F7D-AAEC-6D5F4A792A32Q39301644-16D62EC1-8247-42DB-B8CA-F095455C1057Q40034329-635AE759-A75E-494D-93C8-833645D8862FQ40306067-64FFE46C-4FDD-4E87-AC3D-3116F8A9B018Q40364413-1EB9E70C-E87B-4605-BAEF-773FAC7754A9Q40738903-EDC78F61-F7D4-4BF5-A622-77BB448CAAFDQ47786477-2A4482E8-84E9-4C3C-98C9-881805513B50Q48022169-ED3D55E7-23BA-4AFD-AFCA-25FC9FF3C541Q48096762-534C7BA1-4D47-4CD4-BF8D-F26D0E70AC95Q52608877-5706EFEE-AE58-4408-9B1F-E1BA81314044Q53781806-55B227F7-CEE0-45D7-B6C8-53157C36B733Q53812943-1A6A3066-5C73-495F-87AE-770998748E9BQ54977291-4FC98CA5-7F79-493A-AA0C-E9E4A08248F8Q58756032-2B6D6389-5F84-4CF5-AE9E-36E6AC8A2D39
P2860
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@ast
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@en
type
label
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@ast
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@en
prefLabel
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@ast
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
@en
P2093
P2860
P50
P356
P1476
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
@en
P2093
Anna Ballard
Carey-Ann D Burnham
Mayland Chang
Mitchell W Pesesky
Shahriar Mobashery
Valerie A Schroeder
William R Wolter
P2860
P2888
P304
P356
10.1038/NCHEMBIO.1911
P577
2015-09-14T00:00:00Z